Roquefort Therapeutics plc (ROQ.L) LSE

1.23

+0.033(+2.75%)

Updated at January 15 11:06AM

Currency In GBp

Valuation

Market Cap5.25M
Enterprise Value5.31M
P/E Ratio-2.06
PEG Ratio-0.13
Price/Sales Ratio0
Price/Book Ratio0.38
Enterprise/Revenue0
Enterprise/EBITDA-2.39

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.16
Return On Equity-0.18

Income Statement

Revenue0
Revenue/Share0
Gross Profit-16,000
EBITDA-1.11M
Net Income-971,803
Diluted EPS-0.01

Balance Sheet

Total Cash182,923
Total Cash/Share0
Total Debt383,650
Total Debt/Equity0.08
Current Ratio2.8
Book Value Per Share0.03

Price History

52-Week Change-69.56
52-Week High4.5
52-Week Low1.08
Moving Average 50 Days1.51
Moving Average 200 Days1.67

Statistics

Average Volume1.92M
Shares Outstanding163.73M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A